logo
logo

Access Vascular, Inc. Secures $20 Million in Series B Financing

Mar 03, 2021over 4 years ago

Amount Raised

$20 Million

Round Type

series b

Bedford

Description

Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. TVM Capital Life Science led the round with a $15 million commitment, with existing investors also participating.

Company Information

Company

Access Vascular

Location

Bedford, Pennsylvania, United States

About

Access Vascular was founded in 2015 to address the most common and costly complications of intravenous therapy: infection, thrombosis and phlebitis. The company is developing a suite of venous access devices made from patented biomaterials which are highly biocompatible and are capable of long-term thrombus resistance.

Related People

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech